| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.37 | 7e-13 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.3 | 6e-12 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-11 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-09 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-06 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.32 | 2e-06 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-06 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |